Cathie Wood recently added to her position in CRISPR Therapeutics stock.
Joby continues to attract Cathie Wood’s backing despite funding pressure and volatility. Does this conviction signal a timely opportunity now?
Marc Chaikin explains why the presidential election cycle, weakening tech stocks, and rising geopolitical risk could signal a correction, and how investors can prepare now.
Cathie Woods’s ARK Invest deploys $19 million across five growth stocks in this uncertain market.
Defense stocks are surging. And Cathie Wood just made a $21 million bet on one name that could be at the center of it all.
Pinterest is growing, but rich multiples and ad headwinds mean Cathie Wood’s trim isn’t a panic signal, just a reminder of execution risk.
Ark Invest added more CRWV stock ahead of the company's Feb. 26 earnings report.
Cathie Wood added Robinhood shares last week amidst a post-earnings selloff.
Nvidia sold its position in Recursion Pharmaceuticals, while others keep a measured outlook. Does this divergence signal risk or opportunity?
Concerns about the software industry are swirling, and Cathie Wood is selling Unity shares. So should you do the same?